About: Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.50 (-2.11%)
ACET NASDAQ Adicet Bio Inc
Adicet Bio Inc share price
ACET price activity
Last Price
$6.560
Change (24hr)
-0.08 USD (-1.20%)
Volume
164.61K
Volume (4w avg)
-
Open
$6.70
Day Range
$6.50 - $6.82
Previous Close
$6.64
Last Trade
02 Oct, 8:00 pm GMT+0
Delayed
02 Oct, 8:00 pm GMT+0
ACET price performance
Delayed
02 Oct, 8:00 pm GMT+0
ACET Market Signals